Becky Cap was named Chief Operating Officer of San Antonio-based GenCure, a subsidiary of BioBridge Global, in February 2016. Under her guidance, GenCure became a biomanufacturing firm providing donor-to-patient services in the regenerative medicine and cellular therapy space. Cap began her career at Dana-Farber Cancer Institute in Boston after earning a bachelor’s degree from Harvard University. While at Dana-Farber, she gained clinical, laboratory and regulatory experience. She developed her foundational knowledge of clinical medicine managing clinical trials focused on hematologic stem cell transplant for breast cancer and the effects of growth factors in high-dose chemotherapy trials. While pursuing her MBA at Boston University’s Health Care Management Program, she moved to industry and began working for Eidetics. She supported US and global development and strategic marketing efforts for chemotherapeutics, targeted therapies and immune-oncology agents. Cap has provided strategic guidance for the development of pharmaceuticals and medical devices, both in large, established firms and early stage ventures.